Published in Health Business Week, February 9th, 2007
"The announcement of a brand name represents a key milestone in the development of AZD2171," commented Ian Triggs, Global Brand Strategy director for AZD2171.
Nick Botwood, Global Medical director for AZD2171, added, "Preclinical data shows this compound is a potent suppressor of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week